Who to call at Halozyme Therapeutics, and when
Fundz watches for the moments Halozyme Therapeutics starts buying, and tells you who to reach.
- An alert the day Halozyme Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Halozyme Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Halozyme Therapeutics. With Fundz connected, it knows.
Contract Type
agreement
Description
Halozyme Therapeutics has announced a new global collaboration with GSK to utilize its ENHANZE technology for subcutaneous delivery of multiple oncology products. This agreement will develop subcutaneous formulations for antibody drug conjugates and introduce potential royalty streams from GSK’s oncology portfolio.
Quick answer
Halozyme Partners with GSK to Enhance Subcutaneous Delivery of Oncology Drugs (May 10, 2026). Halozyme Therapeutics is based in San Diego, California, United States.
- What agreement did Halozyme Therapeutics announce on May 10, 2026?
- Halozyme Therapeutics has announced a new global collaboration with GSK to utilize its ENHANZE technology for subcutaneous delivery of multiple oncology products. This agreement will develop subcutaneous formulations for antibody drug conjugates and introduce potential royalty streams from GSK’s oncology portfolio.
- What does Halozyme Therapeutics do?
- Halozyme is a biopharmaceutical company advancing disruptive solutions to improve patient experiences and outcomes for emerging and established therapies.
- Where is Halozyme Therapeutics based?
- Halozyme Therapeutics is based in San Diego, California, United States.
Source: Fundz verified event record.
Related People
Halozyme Therapeutics signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.